examined the expression of CIRC-100395 in non-small cell lung cancer cells and the interaction among CIRC-100395, miR-141-3p and LATS2, and found that CIRC-100395 in AMSC-EVs could downregulate miR- 141-3p to increase the expression of LATS2, thereby slowing the progression of non-small cell lung cancer. Here, LATS2 is linked to non-small cell lung carcinoma.